Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

The agency outlined the adjustments it's willing to make to "remove barriers and perceived misconceptions" for innovative medicines.

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

The next iPad mini may get a major performance boost with Apple's first 2nm A20 Pro chip, offering faster speeds and longer ...